Our approach
combines clinically validated strains, robust formulation expertise, and a deep understanding of microbiome-host interactions. We collaborate with leading scientists and healthcare professionals to ensure that every product we bring to market meets the highest standards of efficacy, safety, and quality.
A core pillar
of our work is the commitment to rigorous clinical research. We conduct well-designed clinical studies to provide evidence-based confirmation of our products’ efficacy, grounded in clearly defined mechanistic principles. This allows us to translate complex microbiome science into solutions that are not only innovative, but also scientifically substantiated and clinically relevant. At Save Health Microbiome, we recognize the growing global need for personalized and preventive healthcare solutions. By transforming cutting-edge microbiome science into practical, effective products, we aim to empower healthcare providers and patients alike. As a forward-looking partner, we are committed to expanding our international presence, building strong strategic partnerships, and contributing to the future of microbiome-based therapeutics and nutraceuticals.
Save Health Microbiome
is a science-driven company dedicated to advancing human health through targeted microbiome solutions. Built on the latest research in microbiota and its systemic impact, we develop innovative, high-quality products designed to support immune function, gastrointestinal balance, and overall well-being.
2012
Overcoming Challenges: Latopic - Setting the New Standard in Atopic Skin Care
After Latopic entered the market and faced challenges, including a failed truck full of products, we encountered misunderstanding from all sides. We were the first to decide to launch a probiotic with a specific purpose – in this case, a probiotic for atopic dermatitis. However, through perseverance, motivation, and dedication, we succeeded in establishing Latopic as the leading product for atopic dermatitis. We reached a point where it became expected that mothers whose children have this problem would become Latopic users. In this way, we once again became leaders in innovation and setting standards in our industry.
2017
Revolutionizing Health: The Lactibiane Journey Towards Personalized Probiotic Solutions
In 2017, we launched the Lactibiane product line, marking the beginning of our mission of personalized probiotic application. This initiative represented a revolutionary step in the market, as probiotics had primarily been associated with addressing gastrointestinal issues up to that point. Our innovative idea was to provide a personalized approach to probiotic application, which was completely novel and unique at the time.
The initial 7 products immediately garnered attention, becoming synonymous with effective issue resolution. This recognition inspired us to expand our range, introducing new products focused on personalized approaches to micronutrition and phytotherapy. We take pride in remaining unique in the market for our ability to provide solutions tailored to individual patient needs. Today, our portfolio comprises over 50 products aimed at improving the health and well-being of our users.
2018
Advancing Immunity: The Evolution of Imunolak
Guided by our past successes, we decided to create a brand that would bring together our experience, achievements, and knowledge. With a clear vision and a strong commitment to innovation, we turned that idea into reality.
2018 – Imunolak
We pioneered the introduction of Imunolak, the first immunobiotic on the market, developed to support immune function through a carefully selected blend of probiotic strains. Its approach goes beyond supporting immune defenses, aiming to help maintain a balanced immune response.
2021 – Imunolak Adults & Imunolak Kids
Building on our experience, we raised the bar by developing formulations that combine carefully selected probiotic strains with vitamin D3 and zinc in a single capsule. This synergistic approach was designed to provide targeted support for immune health and allergies, supported by scientific and clinical research.
When developing these formulations, we chose a higher dose of vitamin D3—an unconventional approach at the time that presented challenges during the registration process. Guided by scientific evidence, we remained committed to our concept and successfully brought it to market. Today, the dose we initially proposed has become widely accepted for daily use, reflecting our commitment to anticipating future developments in health and nutrition.
2025 – Imunolak Baby
The Imunolak family expanded with Imunolak Baby, a scientifically formulated probiotic designed to support babies from birth, with particular attention to the needs of premature babies and those born by Caesarean section.
Its carefully selected probiotic strains are designed to support the development of a healthy gut microbiota, digestive comfort, immune system development, and the important gut-brain connection during the earliest stages of life. With Imunolak Baby, we extended our expertise to the very beginning of life-supporting a healthy start and development from day one.
